What We're Reading: Page 256
Industry reads hand-picked by our editors
Dec 17, 2018
-
Financial Times
Novartis weighs reinsurance tie-up to fund ultra-expensive drugs
-
in-PharmaTechnologist
2018: An inflection point for generics
-
The New York Times
Dr. Google is a liar
-
The Washington Post
On a bat's wing and a prayer
Dec 14, 2018
-
Reuters
J&J knew for decades that asbestos lurked in its Baby Powder
-
The BMJ
Key opinion leaders' guide to spinning a disappointing clinical trial result
-
The New York Times
NIH to scrutinize private donations to scientific research projects
-
STAT
China’s history with AIDS explains a puzzling aspect of the 'CRISPR babies’ story
Dec 13, 2018
Dec 12, 2018
-
The New York Times
Seeking Clues to Longevity in Lonesome George’s Genes
-
The Wall Street Journal
Scientists Skeptical About Gene-Edited Baby Experiment
-
STAT
Lawmaker chastises Pfizer for reverting to price hikes next month